Old Web
English
Sign In
Acemap
>
authorDetail
>
Belvia A. Carter
Belvia A. Carter
Internal medicine
Bacterial vaginosis
Placebo
Medicine
Vaginal discharge
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
2021
Jane R. Schwebke
Belvia A. Carter
Arthur S. Waldbaum
Kathy J. Agnew
Jeremy R. A. Paull
Clare F. Price
Alex Castellarnau
Philip McCloud
George R. Kinghorn
Show All
Source
Cite
Save
Citations (5)
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
2021
Clinical Infectious Diseases
Christina A. Muzny
Jane R. Schwebke
Paul Nyirjesy
Gregory Kaufman
Leandro Mena
Gweneth B. Lazenby
Olivia T. Van Gerwen
Keonte J Graves
Janeen L. Arbuckle
Belvia A. Carter
Connette P. McMahon
Scott Eder
Jackie Shaw
Brajesh Pandey
Steven E. Chavoustie
Show All
Source
Cite
Save
Citations (4)
Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis
2020
European Journal of Obstetrics & Gynecology and Reproductive Biology
Steven E. Chavoustie
Belvia A. Carter
Arthur S. Waldbaum
Gilbert G. G. Donders
Klaus Peters
Jane R. Schwebke
Jeremy R. A. Paull
Clare F. Price
Alex Castellarnau
Philip McCloud
George R. Kinghorn
Show All
Source
Cite
Save
Citations (12)
A Phase 3 Randomized, Controlled Trial of Astodrimer 1% Gel for Preventing Recurrent Bacterial Vaginosis
2020
medRxiv
Jane R. Schwebke
Belvia A. Carter
Arthur S. Waldbaum
Kathy J. Agnew
Jeremy R. A. Paull
Clare F. Price
Alex Castellarnau
Philip McCloud
George R. Kinghorn
Show All
Source
Cite
Save
Citations (0)
1